title: [Controversies in the treatment of Helicobacter pylori].
abstract: Helicobacter pylori is a worldwide infection. In gastro-duodenal ulcer disease no doubt remains about the necessity of H. pylori eradication. Controversies subsisting in other pathologies such gastro-esophageal reflux, dyspepsia, gastritis, gastric adenocarcinoma or MALT lymphoma are reviewed. Multiple drug combinations have been proposed to cure the infection. These are discussed in the clinical setting of Belgian practice.
authors.affiliation: Service d'Hépato-Gastroentérologie, Université de Liège.
authors.forename: C
authors.initials: C
authors.lastname: Van Kemseke
authors.forename: J
authors.initials: J
authors.lastname: Belaiche
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004415:Dyspepsia / Q000209:etiology / Q000382:microbiology; D005756:Gastritis / Q000209:etiology / Q000382:microbiology; D005764:Gastroesophageal Reflux / Q000209:etiology / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications* / Q000473:pathology; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000209:etiology / Q000382:microbiology; D013276:Stomach Ulcer / Q000209:etiology / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents